-
Dr.Lise Gehrt Cardél has led a groundbreaking study that sheds new light on the broader health benefits of the measles-mumps-rubella (MMR) vaccine
Dr.Lise Gehrt Cardél has led a groundbreaking study that sheds new light on the broader health benefits of the measles-mumps-rubella (MMR) vaccine. This large-scale, nationwide cohort study across Denmark, Finland, Norway, and Sweden found that children who received MMR after the diphtheria-tetanus-acellular pertussis (DTaP) vaccine had lower rates of infectious disease hospitalizations, suggesting potential non-specific…
-
Dr. Petek Eylül Taneri, MD, PhD has led a landmark study published in JAMA Network Open
Dr. Petek Eylül Taneri, MD, PhD has led a landmark study published in JAMA Network Open, setting a new standard for neonatal sepsis research. The Neonatal Sepsis Core Outcome Set (NESCOS) is a global consensus that defines the key outcomes to be measured in all future studies on neonatal sepsis, ensuring consistency, comparability, and impact.
-
Advancing Treatment for Metastatic Triple-Negative Breast Cancer: Dr. Aditya Bardia’s Work in the ASCENT Trial
On May 20, 2024, Dr. Aditya Bardia and his colleagues published the final results of the Phase III ASCENT trial, reinforcing Sacituzumab Govitecan (SG) as a superior treatment option over…
-
Annual Review | Dr. Ou Bai: Focusing on Advances and Challenges in PTCL Diagnosis and Treatment in 2024
In recent years, the field of hematologic oncology has seen numerous encouraging breakthroughs, with Chinese scholars increasingly contributing to research in cell therapy, significantly advancing the development of both the discipline and clinical practice. Hematology Frontier specially invited Dr. Ou Bai from The First Bethune Hospital of Jilin University to discuss the progress in the…
-
Dr. Zhanhong Chen: Exploring New Treatment Pathways for HR+ Advanced Breast Cancer – The Future Role of CDK4/6 Inhibitors and Novel Targeted Therapies
In the evolving landscape of breast cancer treatment, the management of HR+ advanced breast cancer remains a central focus. During the Northern China Breast Cancer Salon – Annual Progress Review, Dr. Zhanhong Chen from Zhejiang Cancer Hospital delivered an in-depth analysis on the stratified treatment approach for HR+ advanced breast cancer. Following the meeting, Oncology…
-
ASCO GI 2025 | Dr. Zhenyu Lin: Short-Course Radiotherapy Plus Targeted, Immuno-, and Chemotherapy for High-Risk LA
At the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI 2025), the UNION TNT study, led by Dr. Tao Zhang and Dr. Kaixiong Tao from the Multidisciplinary…
-
European Hematology Association (EHA) Conference Highlights ！
The curtains have closed on another enlightening EHA Congress, a beacon of innovation in hematology. This year’s gathering was a testament to the relentless pursuit of medical advancement, with a…
-
ASCO GI 2025 | Dr. Zhiqiang Wang: Significant Advantages of Albumin-Bound Docetaxel in Second-Line Treatment for Advanced Gastric Cancer
As one of the most important academic conferences in the field of gastrointestinal oncology, the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) presents a wealth of early-phase drug development data, key registration studies, major research updates, and subgroup analyses every year. These findings represent the latest advancements in the diagnosis and treatment…
Connecting Medical Expertise through Media